国际放射医学核医学杂志
國際放射醫學覈醫學雜誌
국제방사의학핵의학잡지
INTERNATIONAL JOURNAL OF RADIATION MEDICINE AND NUCLEAR MEDICINE
2014年
3期
190-196
,共7页
受体,趋化因子%肿瘤%分子显像
受體,趨化因子%腫瘤%分子顯像
수체,추화인자%종류%분자현상
Receptors,chemokine%Neoplasms%Molecular imaging
CXC型趋化因子受体4(CXCR4)及CXC型趋化因子配体12(CXCL12)在肿瘤生长、新生血管形成和远处转移等方面发挥了至关重要的作用。两者结合后可以激活下游信号通路,从而发挥促进肿瘤生长和血管生成的作用。肿瘤组织高表达CXCR4,而肿瘤较常发生转移的部位高表达CXCL12,两者之间可通过特异性的结合而促使肿瘤发生转移。因此,CXCR4的表达水平在肿瘤转移的诊断方面具有预示性的作用,而无创性的影像学诊断方法,如SPECT/CT、PET显像等,有望在CXCR4的显像方面发挥重要作用,从而实现肿瘤的早期诊断和早期治疗。
CXC型趨化因子受體4(CXCR4)及CXC型趨化因子配體12(CXCL12)在腫瘤生長、新生血管形成和遠處轉移等方麵髮揮瞭至關重要的作用。兩者結閤後可以激活下遊信號通路,從而髮揮促進腫瘤生長和血管生成的作用。腫瘤組織高錶達CXCR4,而腫瘤較常髮生轉移的部位高錶達CXCL12,兩者之間可通過特異性的結閤而促使腫瘤髮生轉移。因此,CXCR4的錶達水平在腫瘤轉移的診斷方麵具有預示性的作用,而無創性的影像學診斷方法,如SPECT/CT、PET顯像等,有望在CXCR4的顯像方麵髮揮重要作用,從而實現腫瘤的早期診斷和早期治療。
CXC형추화인자수체4(CXCR4)급CXC형추화인자배체12(CXCL12)재종류생장、신생혈관형성화원처전이등방면발휘료지관중요적작용。량자결합후가이격활하유신호통로,종이발휘촉진종류생장화혈관생성적작용。종류조직고표체CXCR4,이종류교상발생전이적부위고표체CXCL12,량자지간가통과특이성적결합이촉사종류발생전이。인차,CXCR4적표체수평재종류전이적진단방면구유예시성적작용,이무창성적영상학진단방법,여SPECT/CT、PET현상등,유망재CXCR4적현상방면발휘중요작용,종이실현종류적조기진단화조기치료。
CXC chemokine receptor type 4 (CXCR4) and its ligand (CXCL12) exerts crucial influence in regulating tumor growth, angiogenesis and metastasis. Studies show that the downstream sig-naling pathway can be activated by interaction of the chemokine receptor and its ligand to promote tumor growth and angiogenesis. Additional observation suggests that neoplastic tissue expresses high levels of CXCR4, and the site of tumor metastasis over expresses CXCL12, through which this specific binding abil-ity can induce tumor metastasis. Thus, the CXCR4 levels could be used as a predictive marker of metastat-ic potential. Hopefully, the non-invasive imaging methods, such as SPECT/CT, PET, are employed in the imaging of the chemokine receptors to diagnose and treat the tumors in the early stage.